Stock CLXP.F CYBIN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cybin Inc. OTC Markets

Equities

CLXP.F

CA23256X1006

End-of-day quote OTC Markets
Other stock markets
 03:30:00 01/09/2021 am IST 		5-day change 1st Jan Change
2.63 CAD -6.07% Intraday chart for Cybin Inc. +17.41% +76.51%
11/06 Cybin Inc. Appoints Atul R. Mahableshwarkar as Senior Vice President, Clinical Development CI
06/05 Cybin Provides Corporate Provides Update Highlighting Recent Clinical Accomplishments and Key Upcoming Catalysts Across Its Development Pipeline CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 114B
BIONTECH SE Stock BioNTech SE
 20.43B -
GENMAB A/S Stock Genmab A/S
 16.55B
BEIGENE, LTD. Stock BeiGene, Ltd.
 16.45B -
  1. Stock Market
  2. Equities
  3. CYBN Stock
  4. CLXP.F Stock
  5. Charts Cybin Inc.
  6. Sector Chart